Gender specific effect of progesterone on myocardial ischemia/reperfusion injury in rats

Life Sciences

Volumn 81, Issue 3, 2007, Pages 188-197

  Dhote, Vipin V ^a   Balaraman, R ^a  

^a M S UNIVERSITY OF BARODA   (India)

Author keywords

Gender; Ischemia reperfusion; MPO; Progesterone

Indexed keywords

BIOLOGICAL MARKER; CREATINE KINASE; DNA FRAGMENT; ESTROGEN; GLUTATHIONE; MYELOPEROXIDASE; PROGESTERONE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; GENDER; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART RATE; HEART VENTRICLE TACHYCARDIA; HEMODYNAMICS; HISTOLOGY; INCIDENCE; INFLAMMATION; LEFT CORONARY ARTERY; LIPID PEROXIDATION; MALE; NONHUMAN; OVARIECTOMY; OXIDATIVE STRESS; RAT; REPERFUSION INJURY; ST SEGMENT ELEVATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ARRHYTHMIA; BIOLOGICAL MARKERS; BLOOD PRESSURE; CORONARY VESSELS; CREATINE KINASE; DNA FRAGMENTATION; ELECTROCARDIOGRAPHY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HEART RATE; MALE; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; MYOCYTES, CARDIAC; OVARIECTOMY; OXIDATIVE STRESS; PEROXIDASE; PROGESTERONE; RATS; RATS, SPRAGUE-DAWLEY; SEX CHARACTERISTICS;

ANIMALIA; RATTUS;

EID: 34250855042     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2007.05.010     Document Type: Article

References (73)

1. Abramov D., Tamariz M.G., and Sever J.Y. The influence of gender on the outcome of coronary artery bypass surgery. Annals of Thoracic Surgery 70 (2000) 800-805
2. Aebi H. Catalase in vitro. Methods in Enzymology 105 (1984) 121-126
3. Alkayed N.J., Harukuni I., Kimes A.S., London E.D., Traystman R.J., and Hurn P.D. Gender-linked brain injury in experimental stroke. Stroke 29 (1998) 159-166
4. Balaraman R., Gulati O.D., Bhatt J.D., Rathod S.P., and Hemavathi K.G. Cadmium induced hypertension in rats. Pharmacology 38 (1989) 226-234
5. Baldus S., Heitzer T., Eiserich J.P., Lau Y.D., Mollnau H., Ortak M., Petri S., Goldmann B., Duchstein H.J., Berger J., Helmchen U., Freeman B.A., Meinertz T., and Nzel T.M. Myeloperoxidase enhances nitric oxide catabolism during myocardial ischemia and reperfusion. Free Radical Biology & Medicine 37 (2004) 902-911
6. Bauldry S.A., Bass D.A., and Cousart S.L. Tumor necrosis factor-alpha priming of phospholipase D in human neutrophils. Correlation between phosphatidic acid production and superoxide generation. Journal of Biological Chemistry 266 (1991) 4173-4179
7. Becker L.B. New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovascular Research 61 (2004) 461-470
8. Behl C. Oestrogen as a neuroprotective hormone. Nature Reviews 3 (2002) 433-442
9. Bolli R., and Marban E. Molecular and cellular mechanisms of myocardial stunning. Physiological Reviews 79 (1999) 609-634
10. Bradley P.P., Priebat D.A., Christensen R.D., and Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. Journal of Investigative Dermatology 78 (1982) 206-209
11. Bramlett H.M. Sex differences and the effect of hormonal therapy on ischemic brain injury. Pathophysiology 12 (2005) 17-27
12. Bridgman P., Aronovitz M.A., and Kakkar R. Gender-specific patterns of left ventricular and myocyte remodeling following myocardial infarction in mice deficient in the angiotensin II type 1a receptor. American Journal of Physiology. Heart and Circulatory Physiology 289 (2005) H586-H592
13. Bushnell C.D. Oestrogen and stroke in women: assessment of risk. Lancet Neurology 4 (2005) 743-751
14. Butterworth J., Prielipp J.R., Cerese J., Livingston J., and Burnett D. Female gender associates with increased duration of intubation and length of stay after coronary artery surgery. CABG clinical benchmarking database participants. Anesthesiology 92 (2000) 414-424
15. Cannon J.G., and Dinarello C.A. Increased plasma interleukin-1 activity in women after ovulation. Science 227 (1985) 1247-1249
16. Das D.K., Cordis G.A., Rao P.S., Liu X.K., and Maity S. High-performance liquid chromatographic detection of hydroxylated benzoic acids as an indirect measure of hydroxyl radical in heart: its possible link with the myocardial reperfusion injury. Journal of Chromatography 536 (1991) 273-282
17. Edwards F.H., Carey J.S., Grover F.L., Bero J.W., and Hartz R.S. Impact of gender on coronary bypass operative mortality. Annals of Thoracic Surgery 66 (1998) 125-131
18. Farhat M.Y., and Ramwell P.W. Estradiol potentiates the vasopressor response of the isolated perfused rat lung to the thromboxane mimic U-46619. Journal of Pharmacology and Experimental Therapeutics 261 (1992) 686-691
19. Fiorentino D.F., Zlotnik A., Vieira P., Mosmann T.R., Howard M., Moore K.W., and O'Garra A. IL-10 acts on antigen-presenting cell to inhibit cytokine production by Th1 cells. Journal of Immunology 146 (1991) 3444-3451
20. Fliss H., and Gattinger D. Apoptosis in ischemic and reperfused rat myocardium. Circulation Research 79 (1996) 949-956
21. Galang N., Sasaki H., and Maulik N. Apoptotic cell death during ischemia/reperfusion and its attenuation by antioxidant therapy. Toxicology 148 (2000) 111-118
22. Gandolfo M.T., Verzola D., Salvatore L., Gianiorio G., Procopio V., Romagnoli A., Giannoni M., and Garibotto G. Gender and progression of chronic renal diseases: does apoptosis makes a difference?. The Italian Journal of Urology and Nephrology 56 (2006) 1-14
23. Gibson C.L., Constantin D., Prior M.J.W., Bath P.M.W., Sean P., and Murphy S.P. Progesterone suppresses the inflammatory response and nitric oxide synthase-2 expression following cerebral ischemia. Experimental Neurology 193 (2005) 522-530
24. Gottlieb R.A., Burleson K.O., Kloner R.A., Babior B.M., and Engler R.L. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. The Journal of Clinical Investigations 94 (1994) 1621-1628
25. Gottlieb R.A., Giesing H.A., Engler R.L., and Babior B.M. The acid deoxyribonuclease of neutrophils: a possible participant in apoptosis-associated genome destruction. Blood 86 (1995) 2414-2418
26. Hamilton K.L., Staib J.L., Phillips T., Hess A., Lennon S.L., and Powers S.K. Exercise, antioxidants, and hsp72: protection against myocardial ischemia/reperfusion. Free Radical Biology & Medicine 34 (2003) 800-809
27. Hess M.L., Barnhart G.R., Crute S., Komwatana P., Krause S., and Greenfield L.J. Mechanical and biochemical effects of transient myocardial ischemia. Journal of Surgical Research 26 (1979) 175-184
28. Hurn P.D., Vannucci S.J., and Hagberg H. Adult or perinatal brain injury: does sex matter?. Stroke 36 (2005) 193-195
29. Itoh G., Tamura J., Suzuki M., Suzuki Y., Ikeda H., Koike M., Nomura M., Jie T., and Ito K. DNA fragmentation of human infarcted myocardial cells demonstrated by the nick end labeling method and DNA agarose gel electrophoresis. The American Journal of Pathology 146 (1995) 1325-1331
30. Jain M., Liao R., Podesser B.K., Ngoy S., Apstein C.S., and Eberli F.R. Influence of gender on the response to hemodynamic overload after myocardial infarction. The American Journal of Physiology-Heart Circulatory Physiology 283 (2002) H2544-H2550
31. Jeroudi M.O., Hartley C.J., and Bolli R. Myocardial reperfusion injury: role of oxygen radicals and potential therapy with antioxidants. The American Journal of Cardiology 73 (1994) 2B-7B
32. Jiang N., Chopp M., Stein D., and Feit H. Progesterone is neuroprotective after transient middle cerebral artery occlusion in male rats. Brain Research 735 (1996) 101-107
33. Kjekshus J.K., and Sobel B.E. Depressed myocardial creatine phosphokinase activity following experimental myocardial infarction in rabbit. Circulation Research 27 (1970) 403-414
34. Kleber A.G. ST-segment elevation in the electrocardiogram: a sign of myocardial ischemia. Cardiovascular Research 45 (2000) 111-118
35. Kleber A.G., Janse M.J., Van Capelle F.J.C., and Durrer D. Mechanism and time course of S-T and T-Q segment changes during acute regional myocardial ischemia in the pig heart determined by extracellular and intracellular recordings. Circulation Research 42 (1978) 603-613
36. Kutala V.K., Khan M., Mandal R., Ganesan L.P., Tridandapani S., Kalai T., Hideg K., and Kuppusamy P. Attenuation of myocardial ischemia-reperfusion injury by trimetazidine derivatives functionalized with antioxidant properties. Journal of Pharmacology and Experimental Therapeutics 317 3 (2006) 921-928
37. Kwang K.K., and Ichiro S. Should progestins be blamed for the failure of hormone replacement therapy to reduce cardiovascular events in randomized controlled trials?. Arteriosclerosis, Thrombosis, and Vascular Biology 7 (2004) 1171-1179
38. Li D., Li C.Y., Yong A.C., and Kilpatrick D. Source of electrocardiographic ST changes in subendocardial ischemia. Circulation Research 82 (1998) 957-970
39. Lorenzo V.C., Garcia-Rodriguez L.A., Perez-Gutthann S., and Duque-Oliart A. Hormone replacement therapy and incidence of acute myocardial infarction. A population-based nested case-control study. Circulation 101 (2000) 2572-2578
40. Lowery O.H., Rosenbrough N.J., Farr Al., and Randall R.J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193 (1951) 265-275
41. Majno G., and Joris I. Apoptosis, oncosis, and necrosis: an overview of cell death. The American Journal of Pathology 146 (1995) 3-15
42. Misra H.P., and Fridovich L. The role of superoxide anions in the auto-oxidation of epinephrine and simple assay for superoxide dismutase. Journal of Biological Chemistry 247 (1972) 3170-3175
43. Moffatt C.A., Rissman E.F., Shupnik M.A., and Blaustein J.D. Induction of progestin receptors by estradiol in the forebrain of estrogen receptor-alpha gene-disrupted mice. Journal of Neuroscience 18 (1998) 9556-9563
44. Moron M.S., Depierre J.W., and Mannervik B. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochimica et Biophysica Acta 582 (1979) 67-78
45. Mosmann T.R. Properties and functions of interleukin-10. Advances in Immunology 56 (1994) 1-26
46. Murphy S.J., Traystaman R.J., and Hurn P.D. Progesterone exacerbates striatal stroke injury in progesterone-deficient female animals. Stroke 31 (2003) 1173-1178
47. Perez Gutthann S., Garcia Rodriguez L.A., Castellsague J., and Duque Oliart A. Hormone replacement therapy and risk of venous thromboembolism: population based case-control study. British Medical Journal 314 (1997) 796-800
48. Roof R.L., and Hall F.D. Gender differences in acute CNS trauma and stroke: neuroprotective effects of estrogen and progesterone. Journal of Neurotrauma 17 (2000) 367-388
49. Roof R.L., Duvdevani R., and Stein D.G. Gender influences outcome of brain injury; progesterone plays a protective role. Brain Research 607 (1993) 333-336
50. Roof R.L., Duvdevani R., Heyburn J.W., and Stein S.G. Progesterone rapidly decreases brain edema: treatment delayed up to 24 hours is still effective. Experimental Neurology 138 (1996) 246-251
51. Rosano G.M.C., Webb C.M., Chierchia S., Morgani G.L., Gabraele M., Sarrel P.M., de Ziegler D., and Collins P. Natural progesterone, but not medroxyprogesterone acetate, enhances the beneficial effect of estrogen on exercise-induced myocardial ischemia in postmenopausal women. Journal of The American College of Cardiology 36 (2000) 2154-2159
52. Saks V.A., Khuchua Z.A., Vasilyeva E.V., Belikova O.Y., and Kuznetsov A.V. Metabolic compartmentation and substrate channeling in muscle cells: role of coupled creatine kinases in in vivo regulation of cellular respiration: a synthesis. Molecular and Cellular Biochemistry 133 (1994) 155-192
53. Santos R.L., Abreu G.R., Bissoli N.S., and Moysés M.R. Endothelial mediators of 17b-estradiol-induced coronary vasodilation in the isolated rat heart. Brazilian Journal of Medical and Biological Research 37 4 (2004) 569-575
54. Schumacher M., Guennoun R., and Robert F. Local synthesis and dual actions of progesterone in the nervous system: neuroprotection and myelination. Growth Hormone IGF Research 14 (2004) S18-S33
55. Shankar R.A., Hideg K., Zweier J.L., and Kuppusamy P. Targeted antioxidant properties of N-[(tetramethyl-3-pyrroline-3-carboxamido)propyl]phthalimide and its nitroxide metabolite in preventing postischemic myocardial injury. Journal of Pharmacology and Experimental Therapeutics 292 (2000) 838-845
56. Shinghala J.R., and Balaraman R. Antihypertensive effect of 5-HT1A agonist buspirone and 5HT2B antagonist in experimentally induced hypertension in rats. Pharmacology 73 3 (2005) 129-139
57. Simonian N.A., Getz R.L., Leveque J.C., Konardi C., and Coyle J.T. Kainic acid induced apoptosis in neurons. Neuroscience 75 (1996) 1047-1055
58. Sitruk-Ware R. Progestins and cardiovascular risk markers. Steroids 65 (2000) 651-658
59. Slater T.F., and Sawyer B.C. The stimulatory effect of carbon tetrachloride and other halogenoalkanes or peroxidative reactions in rat liver fractions in vitro. Biochemical Journal 123 (1971) 805-814
60. Sobel B.E., Bresnahan G.F., Shell W.E., and Yoder R.D. Estimation of infarct size in man and its relation to prognosis. Circulation 46 (1972) 640-648
61. Stampfer M.J., Coldifz G.A., and Willett W.C. Post-menopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. The New England Journal of Medicine 325 (1991) 756-762
62. Stefanick M.L., Cochrane B.B., Hsia J., Barad D.H., Liu J.H., and Johnson S.R. The Women's Health Initiative postmenopausal hormone trials: over-view and baseline characteristics of participants. Annals of Epidemiology 13 9 suppl (2003) S78-S86
63. Tienfenbacher C.P., Kaptiza J., Dietz V., Lee C.H., and Niroomand F. Reduction of myocardial infarct size by fluvastatin. American Journal of Physiology. Heart and Circulatory Physiology 285 (2003) H59-H64
64. Tischkau S.A., and Ramirez V.D. A specific membrane binding protein for progesterone in rat brain: sex difference and induction by estrogen. Proceedings of the National Academy of Sciences of the United States of America 90 (1993) 1285-1289
65. Trentzsch H., Stewart D., and De Maio A. Genetic background conditions the effect of sex steroids on the inflammatory response during endotoxic shock. Critical Care Medicine 31 (2003) 232-236
66. Vakeva A.P., Agah A., and Rollins S.A. Myocardial infarction and apoptosis after myocardial ischemia and reperfusion: role of the acute myocardial terminal complement components and inhibition by anti-C5 therapy. Circulation 97 (1998) 2259-2267
67. Verma S., Fedak P.W.M., Weisel R.D., Butany J., Rao V., Maitland A., Ren-Ke Li., Dhillon B., and Yau T.M. Fundamentals of reperfusion injury for the clinical cardiologist. Circulation 105 (2002) 2332-2336
68. Vinten-Johansen J. Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Cardiovascular Research 61 (2004) 481-497
69. Wang Q.D., Pernow J., Sjoquist P., and Ryden L. Pharmacological possibilities for protection against myocardial reperfusion injury. Cardiovascular Research 55 (2002) 25-37
70. Wang M., Baker L., Tsai B.M., Meldrum K.K., and Meldrum D.R. Sex differences in the myocardial inflammatory response to ischemia-reperfusion injury. American Journal of Physiology: Endocrinology and Metabolism 288 (2005) E321-E326
71. Watts D.C. Creatine kinase (adenosine 5′-triphosphate-creatine phosphotransferase). In: Boyer P.D. (Ed). The Enzyme 8 (1973), Academic Press, New York, NY 383-455
72. White M.M., Zamudio S., Stevens T., Tyler R., Lindenfeld J., Leslie K., and Moore L.G. Estrogen, progesterone, and vascular reactivity: potential cellular mechanisms. Endocrine Reviews 12 (1995) 739-751
73. Zhai P., Eurell E.T., Cottaus R., Jeffery E.H., Bahr J.M., and Gross D.R. Effect of estrogen on global myocardial ischemia-reperfusion injury in female rats. American Journal of Physiology. Heart and Circulatory Physiology 279 (2002) H2766-H2775